Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAM(TM)EGFR V2 and NGS Technologies

BACKGROUND AND OBJECTIVES: The use of ultra-sensitive diagnostic tests to detect clinically actionable somatic alterations within the gene encoding the epidermal growth factor receptor (EGFR) within circulating cell-free DNA is an important first step in determining the eligibility of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Jessica, Gauthier, Arnaud, Lescuyer, Gaëlle, Barthelemy, David, Geiguer, Florence, Balandier, Julie, Edelstein, Daniel L., Jones, Frederick S., Holtrup, Frank, Duruisseau, Mickael, Grolleau, Emmanuel, Rodriguez-Lafrasse, Claire, Merle, Patrick, Couraud, Sébastien, Payen, Léa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956937/
https://www.ncbi.nlm.nih.gov/pubmed/33660188
http://dx.doi.org/10.1007/s40291-021-00515-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956937/
https://www.ncbi.nlm.nih.gov/pubmed/33660188
http://dx.doi.org/10.1007/s40291-021-00515-9

Ejemplares similares